control group:Methylprednisolone

3 trials

Sponsors

Liaocheng People's Hospital, The University of Hong Kong-Shenzhen Hospital, Fujian Medical University Second Hospital

Conditions

Immune thrombocytopeniaThyroid associated ophthalmopathydrug eruption

Phase 4

Recombinant human interleukin-11 (Teer Kang) combined with glucocorticoid treatment of immune thrombocytopenia: a randomized controlled study

RecruitingChiCTR-IPR-15006397

Fujian Medical University Second HospitalImmune thrombocytopenia

Start: 2015-06-15Updated: 2017-04-18

Efficacy and safty study of combined treatment of methylprednisolone and radiation therapy in active thyroid-associated ophthalmopathy patients

Active, not recruitingChiCTR1800017083

Liaocheng People's HospitalThyroid associated ophthalmopathy

Start: 2018-09-01Updated: 2018-07-16

A randomized, multicenter, positive drug controlled clinical study protocol to evaluate the efficacy and safety of adalimumab in adults with exanthematous and severe drug eruptions

Active, not recruitingChiCTR2200067227

The University of Hong Kong-Shenzhen Hospitaldrug eruption

Start: 2023-01-01Updated: 2023-05-15